Equity to Asset ratio is calculated as total stockholders equity divided by total asset. 10x Genomics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $741.0 Mil. 10x Genomics's Total Assets for the quarter that ended in Dec. 2023 was $965.1 Mil.
Therefore, 10x Genomics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.77.
The historical rank and industry rank for 10x Genomics's Equity-to-Asset or its related term are showing as below:
TXG'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.77 Med: 0.77 Max: 0.8
Current: 0.77
During the past 7 years, the highest Equity to Asset Ratio of 10x Genomics was 0.80. The lowest was -1.77. And the median was 0.77.
TXG's Equity-to-Asset is ranked better than 84.8% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 0.47
vs TXG: 0.77
10x Genomics Equity-to-Asset Historical Data
The historical data trend for 10x Genomics's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 10x Genomics's Equity-to-Asset
For the Health Information Services subindustry, 10x Genomics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
10x Genomics's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where 10x Genomics's Equity-to-Asset falls into.
10x Genomics Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
10x Genomics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
10x Genomics Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of 10x Genomics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TXG has been successfully added to your 